What Is Driving the New Fair Value Estimate for Sight Sciences? Sight Sciences now carries a fair value estimate of US$9.35 per share in the updated model, compared with a prior figure of US$7.85. The ...

Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative ...

Manjool Shah, MD, clinical associate professor of ophthalmology and visual sciences for the Kellogg Eye Center, discussed how ...

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

Please provide your email address to receive an email when new articles are posted on . After 1 year, patients with gas-permeable contact lenses had about 10 ETDRS letters greater visual acuity ...

Glaucoma specialists are marking their calendars for January 31, 2026—when the 2nd International Glaucoma Symposium will take ...

To yield the benefits of interventional glaucoma treatment, ophthalmologists need a roadmap for how to implement it, according to a speaker here. At the Hawaiian Eye 2026 meeting, Christine Funke, MD, ...

A new study warns that a widely used eye ointment can damage a popular glaucoma implant. Researchers found that oil-based ...

New Delhi [India], December 31 (ANI): In a landmark achievement for Indian medicine, the Ophthalmology Department at Army Hospital (Research & Referral), Delhi Cantt, has successfully performed ...

I was asked if I'd like to review the LiberNovo Omni, an $1,100 ergonomic desk chair. I mean, have you ever sat in a $1,100 desk chair? I hadn't. I wanted to. I'll start by saying that it's difficult ...

Detailed price information for Sight Sciences Inc (SGHT-Q) from The Globe and Mail including charting and trades.